LTGO — Latigo Biotherapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 2056611 ·
Last close
$13.76
Market Cap
$912.28M
52W High
$25.93
52W Low
$10.24
ADV30
276,827
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -22,929,000 -20,949,000 408,456,000 401,241,000 14,482,000
Jun 2026 0 — -25,808,000 -25,797,000 64,760,000 55,003,000 340,840,000
Mar 2026 0 — -23,436,000 -22,961,000 50,581,000 42,177,000 303,160,000
Dec 2025 0 — -38,412,000 -37,584,000 75,516,000 69,437,000 307,190,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-91,066,000
Investing CF
$-245,000
Financing CF
$133,382,000
CapEx
$-135,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.01
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-291,889,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-96,329,000
Pretax Income TTM
$-95,545,000
Interest Exp TTM
$251,000
Analysts
4

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -110,392,000 -109,167,000 75,516,000 307,190,000 -231,674,000 -97,557,000
Dec 2024 0 -63,451,000 -61,183,000 22,864,000 152,463,000 -129,599,000 -50,955,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$64,760,000
Forward EPS
$-2.09

Peers — same industry

TickerNameMarket CapLastDaily %
VSTM Verastem, Inc. $933.77M $7.41 —
AKTS Aktis Oncology, Inc. $879.52M $16.31 —
MLTX MoonLake Immunotherapeutics $957.45M $11.25 —
CRVS Corvus Pharmaceuticals, Inc. $857.87M $10.17 —
SPTX Seaport Therapeutics, Inc. $972.65M $18.17 —

News headlines (Yahoo Finance, 1h cache)

Latigo Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
2026-11-05 11:47 · Yahoo
Latigo Biotherapeutics Announces CEO Transition to Support the Company’s Next Phase of Growth
2026-11-05 11:45 · Yahoo
Latigo Biotherapeutics to Participate in Upcoming Investor Conferences in November
2026-11-03 21:05 · Yahoo
The Market Barely Knows These 2 IPO Stocks — Goldman Sachs Says ‘Buy’
2026-09-08 18:01 · Yahoo
Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
2026-09-03 20:05 · Yahoo
Latigo Biotherapeutics (LTGO) On IPO And Trial Data Looks About Right Valued
2026-08-10 03:19 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.